This study demonstrated extensive brain white matter alterations in pediatric SMA types 2 and 3, which is responsive to the effects of SMN protein deficit on brain white matter since individuals with SMA types 2 and 3 are less likely to be affected by ischemic-hypoxic encephalopathy [13]. This evidence concerns the gene SMN1 and perinatal asphyxia.